PharmaCyte Biotech (PMCB) Ownership - Who Owns PharmaCyte Biotech?
PharmaCyte Biotech (PMCB) Ownership Overview
- 6.93% Insiders
- 1.51% Mutual Funds
- <0.01% Other Institutional Investors
- 0.53% ETFs
- 91.03% Public Companies and Individual Investors
The ownership structure of PharmaCyte Biotech (PMCB) stock is a mix of institutional, retail, and individual investors. Approximately 2.04% of the company’s stock is owned by Institutional Investors, 6.93% is owned by Insiders, and 91.03% is owned by Public Companies and Individual Investors.
The ownership structure of PharmaCyte Biotech (PMCB) stock is a mix of institutional, retail, and individual investors. Approximately 2.04% of the company’s stock is owned by Institutional Investors, 6.93% is owned by Insiders, and 91.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jan 06, 2026 | Joshua Silverman | $80,000 | |
| Jan 06, 2026 | Jonathan Schechter | $48,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Joshua Silverman | 466,250 | Insider | 4.34% | 140,808 |
| Jonathan Schechter | 192,500 | Insider | 1.79% | 58,135 |
| Fidelity Concord Street Trust | 103,838 | Institution | 0.97% | 31,359 |
| Vanguard | 56,778 | Institution | 0.53% | 17,147 |
| Vanguard Index Funds | 56,778 | Institution | 0.53% | 17,147 |
| Robert Weinstein | 41,250 | Insider | 0.38% | 12,458 |
| Abecassis Michael M | 23,092 | Insider | 0.22% | 6,974 |
| Wayne Remell Walker | 20,625 | Insider | 0.19% | 6,229 |
| Victory Portfolios Iii | 1,804 | Institution | 0.02% | 545 |
| BlackRock, Inc. | 1 | Institution | <0.01% | 0 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 103,838 | Institution | 0.97% | 31,359 |
| Vanguard Index Funds | 56,778 | Institution | 0.53% | 17,147 |
| Victory Portfolios Iii | 1,804 | Institution | 0.02% | 545 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXF ETF | 56,778 | Institution | 0.53% | 23,313 |
FAQ
Who Owns PharmaCyte Biotech (PMCB)?
According to the latest TipRanks data, approximately 2.04% of the company's stock is held by institutional investors, 6.93% is held by insiders, and 91.03% is held by public companies and individual investors.
What percentage of PharmaCyte Biotech (PMCB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.04% of PharmaCyte Biotech (PMCB) stock is held by institutional investors: 1.51% by mutual funds, 0.53% by ETFs and <0.01% by other institutional investors.
What percentage of PharmaCyte Biotech (PMCB) stock is held by retail investors?
According to the latest TipRanks data, approximately 91.03% of PharmaCyte Biotech (PMCB) stock is held by public companies and individual investors.
Who owns the most shares of PharmaCyte Biotech (PMCB)?
Joshua Silverman owns the most shares of PharmaCyte Biotech (PMCB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
